Sentinel lymph node biopsy (SLNB) is critical to breast cancer staging, yet current assessment methods remain heavily ...

Phase III, randomized, open-label, multicenter trial (BREAK-3) comparing the BRAF kinase inhibitor dabrafenib (GSK2118436) with dacarbazine (DTIC) in patients with BRAFV600E-mutated melanoma. This is ...

Neoadjuvant chemotherapy (NCT) in 466 patients for operable breast cancer: Predictive factors for pathological response. Background: Sentinel lymph nodes (SLN) biopsy is a useful method to assess ...

Reston, VA—The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and 10 other professional societies have issued new appropriate use criteria (AUC) for lymphoscintigraphy in sentinel node ...

Whether a tumor is lobular or a non-special type does not independently predict sentinel node status, as both histological groups demonstrate comparable frequencies of nodal spread and pathological ...

For many patients with breast cancer, deciding whether cancer has spread to nearby lymph nodes still depends on ...

IntroductionLymph node involvement significantly impacts the prognosis of patients with gynecologic cancers, such as vulvar and cervical cancers. Traditional extensive lymph node dissection is ...

Women with node-negative breast cancers 2 cm or smaller and negative preoperative axillary ultrasound results may be safely spared sentinel lymph node biopsy (SLN) biopsy, new research suggests. SLN ...

11.20–11.40 PET/CT and PET/MR in Gynecological Malignancies (I.Burger)11.40–13.40 Lunch 13.40–14.40 Round Table/Discussion: Issues on setting and strengthening a PET/CT program in Eastern Europe (all ...

Please provide your email address to receive an email when new articles are posted on . Skipping sentinel lymph node biopsy can be considered for node-negative, HR-positive, HER2-negative early breast ...